- Home
- FCO vs INCR Comparison
FCO vs INCR Comparison
Compare FCO & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCO
- INCR
- Stock Information
- Founded
- FCO 1991
- INCR 1994
- Country
- FCO United Kingdom
- INCR Israel
- Employees
- FCO N/A
- INCR N/A
- Industry
- FCO Investment Managers
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- FCO Finance
- INCR Health Care
- Exchange
- FCO Nasdaq
- INCR Nasdaq
- Market Cap
- FCO 85.6M
- INCR 84.5M
- IPO Year
- FCO N/A
- INCR N/A
- Fundamental
- Price
- FCO $6.41
- INCR $1.46
- Analyst Decision
- FCO
- INCR
- Analyst Count
- FCO 0
- INCR 0
- Target Price
- FCO N/A
- INCR N/A
- AVG Volume (30 Days)
- FCO 100.1K
- INCR 11.6K
- Earning Date
- FCO 01-01-0001
- INCR 08-15-2025
- Dividend Yield
- FCO 14.96%
- INCR N/A
- EPS Growth
- FCO N/A
- INCR N/A
- EPS
- FCO 0.43
- INCR N/A
- Revenue
- FCO N/A
- INCR $65,575,323.00
- Revenue This Year
- FCO N/A
- INCR $69.54
- Revenue Next Year
- FCO N/A
- INCR $41.75
- P/E Ratio
- FCO $12.30
- INCR N/A
- Revenue Growth
- FCO N/A
- INCR N/A
- 52 Week Low
- FCO $4.73
- INCR $1.17
- 52 Week High
- FCO $6.63
- INCR $2.62
- Technical
- Relative Strength Index (RSI)
- FCO 60.54
- INCR 46.71
- Support Level
- FCO $6.16
- INCR $1.43
- Resistance Level
- FCO $6.41
- INCR $1.56
- Average True Range (ATR)
- FCO 0.09
- INCR 0.06
- MACD
- FCO -0.00
- INCR -0.00
- Stochastic Oscillator
- FCO 82.14
- INCR 46.15
About FCO abrdn Global Income Fund Inc.
abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets and Sub-Investment Grade Developing Markets.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.